-+ 0.00%
-+ 0.00%
-+ 0.00%
SQM (NYSE:SQM) Stock Jumps On Record Lithium Sales And Big Capex Bet
Share
Listen to the news

Sociedad Química y Minera de Chile jumped about 4% today to around US$78, as investors rushed to price in a powerful Q2 2026 print rather than wait for the dust to settle. The headline is simple. Lithium did the heavy lifting, with record quarterly sales above 84,000 tonnes of lithium carbonate equivalent and Q2 revenue of US$2,468.3m and basic earnings per share of US$2.31 putting fresh earnings power on the table.

That short term surge now meets a very different question for you. How do multi year lithium growth plans, heavy capex and current valuation shape the longer term risk reward in SQM from here?

Impressed by Sociedad Química y Minera de Chile’s strong Q2 print but worried about concentration risk in one lithium focused stock? Compare this move with a broader basket of producers in our 28 best rare earth metal stocks

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs Q2 2025): US$2,468.3m vs. US$1,042.7m (very large increase, more than 2x)
  • Net Income (Excl. Extra Items, Q2 2026 vs Q2 2025): US$660.0m vs. US$88.4m (very large increase, more than 6x)
  • Basic EPS (Q2 2026 vs Q2 2025): US$2.31 vs. US$0.31 (very large increase, more than 7x)
  • Record Lithium Sales Volumes (Q2 2026 vs Q2 2025): Above 84,000 tonnes LCE vs. lower prior year tonnage not specified (new quarterly high for Sociedad Química y Minera de Chile lithium volumes)

Tired of scrolling through earnings tables and raw lithium volume figures for Sociedad Química y Minera de Chile? Get the full financial picture at a glance, including a clear valuation snapshot, in the interactive company report for Sociedad Química y Minera de Chile.

NYSE:SQM Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
NYSE:SQM Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Evaluating SQM’s Lithium Growth Milestones

Supporters of Sociedad Química y Minera de Chile argue that rapid lithium volume growth, low costs and diversification will underpin earnings strength through the current investment cycle. Q2 gives concrete evidence on the volume leg of that story. Record lithium sales above 84,000 tonnes of lithium carbonate equivalent tie directly to the thesis that new capacity and the Novandino JV can outpace broader market growth.

The capital expenditure intensive expansion plan is also moving from promise to execution. Around US$3 billion of 2026 to 2028 capital expenditure is now framed against specific projects, including the Mt Holland expansion, which aims to double spodumene concentrate capacity, and the Salar Futuro plan, where Novandino Litio has already submitted environmental and technical documentation. On diversification, iodine and specialty plant nutrition both contributed with higher prices and volumes, and management is guiding to about 10% volume growth in nutrition, which supports the multi leg earnings narrative.

Reveal where the surface looks calm but the multi year models start to disagree on Sociedad Química y Minera de Chile. Access the street’s revenue, earnings and free cash flow analyst estimates for Sociedad Química y Minera de Chile.

Bear Case on SQM Tests Execution and Policy Gaps

The bearish view on Sociedad Química y Minera de Chile argues that rising global lithium supply, Chilean policy risk and heavy capex will erode long term earnings power even if volumes stay strong. Q2 does not settle that debate. Record lithium sales above 84,000 tonnes and higher group earnings show that feared near term margin collapse has not appeared, helped by lower reported unit costs and firm iodine and nutrition contributions.

However, several bear milestones remain unresolved. The roughly US$3b capex plan for 2026 to 2028 is confirmed, but there is no detailed update on project level returns or buffers for cost overruns. Salar Futuro has moved to environmental submission, yet final approvals and long term terms in Chile are still open. Reliance on tolling partners in China also fits the execution risk argument. The Q2 print weakens the demand side of the bear case, but leaves supply, policy and capex concerns intact.

With Sociedad Química y Minera de Chile committing around US$3b of capex from 2026 to 2028, the real tension is whether cash generation and the balance sheet can carry that load without pressure on dividends or fresh capital. For more detail, see the full liquidity, debt and cash runway breakdown in the financial health analysis of Sociedad Química y Minera de Chile stock.

Stay Ahead Of Your Next Move

If Sociedad Química y Minera de Chile’s record Q2 lithium volumes and multi year capex plan have caught your attention, register for free with Simply Wall St and add it to a Watchlist to watch the share price against fair value and wait for an entry point that fits your plan. Once you are invested, keep the focus on what really matters by using the Portfolio Command Center that filters out noise and highlights only key developments. For long term context and fresh angles, turn to the Community to see how other investors are thinking about risks and opportunities. This way you can surface potential catalysts and red flags early and stay a step ahead of the market.

Seeking Alternatives Beyond SQM?

Fresh stock ideas move quickly. Some are building quiet breakout momentum while others stay under the radar for now. Check these curated lists before the best entry points are caught.

  • Spot companies with income potential before yields compress by scanning the curated 12 dividend fortresses that focus on durability as much as headline payout.
  • Track developments in AI infrastructure spend by reviewing the hand picked 54 AI infrastructure stocks that connect reported earnings with the hardware supporting the trend.
  • Follow cash generative miners with room to move by using the carefully filtered 31 elite gold producer stocks that focus on production quality as much as metal prices.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending